Papaverine hydrochloride
| Code | Size | Price |
|---|
| CDX-P0164-G025 | 25 g | £121.00 |
Quantity:
| CDX-P0164-G100 | 100 g | £340.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
Ambient
Storage:
+4°C
Documents
Further Information
Alternate Names/Synonyms:
6,7-Dimethoxy-1-veratrylisoquinoline; NSC 35443; NCI-C56359
Appearance:
White powder.
CAS:
61-25-6
EClass:
32160000
Form (Short):
liquid
GHS Symbol:
GHS07
Handling Advice:
Keep cool and dry.Protect from light and moisture.
Hazards:
H302
InChi:
InChI=1S/C20H21NO4.ClH/c1-22-17-6-5-13(10-18(17)23-2)9-16-15-12-20(25-4)19(24-3)11-14(15)7-8-21-16;/h5-8,10-12H,9H2,1-4H3;1H
InChiKey:
UOTMYNBWXDUBNX-UHFFFAOYSA-N
Long Description:
Chemical. CAS: 61-25-6. Formula: C20H21NO4 . HCl. MW: 339.4 . 36.5. Synthetic. Alkaloid antispasmodic drug that most usually treats visceral spasm or vasospasm. It has also been used in the treatment of erectile dysfunction. Smooth muscle relaxant and vasodilator. Phosphodiesterase PDE10A inhibitor. Show to have antiviral and antipsychotic activity.
MDL:
MFCD00012745
Molecular Formula:
C20H21NO4 . HCl
Molecular Weight:
339.4 . 36.5
Package Type:
Vial
Precautions:
P264, P270, P301, P312, P330
Product Description:
Alkaloid antispasmodic drug that most usually treats visceral spasm or vasospasm. It has also been used in the treatment of erectile dysfunction. Smooth muscle relaxant and vasodilator. Phosphodiesterase PDE10A inhibitor. Show to have antiviral and antipsychotic activity.
Purity:
>98% (HPLC)
Signal word:
Warning
SMILES:
Cl.COC1=CC=C(CC2=NC=CC3=CC(OC)=C(OC)C=C23)C=C1OC
Solubility Chemicals:
Soluble in DMSO, ethanol or dimethylformamide.
Source / Host:
Synthetic.
Transportation:
Non-hazardous
UNSPSC Category:
Biochemical Reagents
UNSPSC Number:
12352200
Use & Stability:
Stable for at least 2 years after receipt when stored at -20°C.
References
(1) M. Ferrari; Pharmacol. Res. Commun. 6, 97 (1974) | (2) G.H. Whipple; Angiology 28, 737 (1977) | (3) M. Zentgraf, et al.; Urol. Int. 43, 65 (1988) | (4) M. Nokta, et al.; Immunopharmacol. 26, 181 (1993) | (5) J.A. Siuciak, et al.; Neuropharmacol. 51, 386 (2006)
Related Products
| Product Name | Product Code | Supplier |
|---|